• Disease areas
  • Science & technology
  • Partnering & innovation
  • Sustainable business
  • Careers
  • About us
  • Our products
  • Investors
  • News & media
  • Patient help
  • Contact us

Latest news

{{'2022-08-03T14:36:33Z' | dateFormatFilter}}

Novo Nordisk's sales increased by 25% in Danish kroner and by 16% at constant exchange rates to DKK 83.3 billion in the first six months of 2022

Read more

{{'2022-08-03T14:21:55Z' | dateFormatFilter}}

Novo Nordisk's sales increased by 25% in Danish kroner and by 16% at constant exchange rates to DKK 83.3 billion in the first six months of 2022

Read more

{{'2022-07-29T11:43:31Z' | dateFormatFilter}}

Novo Nordisk achieves primary objectives of ONWARDS 3 and 4 trials with once-weekly insulin icodec demonstrating superior reduction in HbA1c vs insulin degludec in ONWARDS 3

Read more

News archive

Career Opportunities

Dear colleague

Please click here to go directly to our internal career site to view all our current job openings.

Here are our current job openings. If there is not a job you are looking for, you are welcome to create a job agent or a candidate profile.

 

 

 

Investors

Share price

{{priceData.date}} {{priceData.time}}

{{priceData.currentPrice}} {{priceData.currency}}
Go to stock watch {{priceData.change}} {{priceData.currency}}

Quick links

Financial results & events News & IR Materials Financial calendar Share information R&D pipeline

Annual Report

Front cover of the Novo Nordisk Annual Report

Annual Report 2021

Novo Nordisk Annual Report

NOVO NORDISK HQ

Novo Nordisk A/S
Novo Alle 1
2880 Bagsværd
Denmark
+45-4444-8888
CVR-no. 24256790

Helpful links

Patient help Suppliers help Product list Contact us Annual Report ESG reporting COVID-19 update Novo Nordisk Foundation

Follow us

LinkedIn YouTube Facebook Twitter Instagram

Find your local office

Select location
© 2022 Novo Nordisk A/S Data Privacy Cookie policy Cookie settings

change